News

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...
A judge has issued a permanent injunction, signaling an Insulet (Nasdaq:PODD) victory in a trade secret case against EOFlow.
Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...
Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...
AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 ...